<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>US Sends Experimental Ebola Drug to Congo — Live Feed</title><link>https://www.live-feeds.com/feed/us-sends-experimental-ebola-drug-to-congo</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/us-sends-experimental-ebola-drug-to-congo/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>US Deploys Experimental Ebola Treatment for Bundibugyo Outbreak</title><link>https://www.live-feeds.com/feed/us-sends-experimental-ebola-drug-to-congo</link><guid isPermaLink="false">https://www.live-feeds.com/feed/us-sends-experimental-ebola-drug-to-congo#u22281</guid><pubDate>Fri, 03 Jul 2026 04:16:38 +0000</pubDate><description>The United States is providing experimental antibody treatments to the Democratic Republic of Congo and Uganda. These efforts support clinical trials targeting the Bundibugyo species of ebolavirus. The World Health Organization announced that trials for two potential treatments began in the DRC on Thursday.What's confirmed:The US is deploying the investigational monoclonal antibody therapy MBP134.MBP134 was developed through a BARDA partnership with Mapp Biopharmaceutical.The World Health Organization announced that trials for two potential treatments began in the DR Congo on Thursday.The curr</description></item>
</channel></rss>